NASDAQ:GNLNGreenlane Stock Price, Forecast & News

Greenlane's stock was trading at $1.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, GNLN stock has increased by 138.9% and is now trading at $3.44. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Greenlane in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Greenlane.

Greenlane is scheduled to release its next quarterly earnings announcement on Monday, June 29th 2020. View our earnings forecast for Greenlane.

Greenlane Holdings (NASDAQ:GNLN) issued its earnings results on Monday, March, 30th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by $0.67. The company had revenue of $37.24 million for the quarter, compared to analyst estimates of $38.88 million. Greenlane had a negative net margin of 14.73% and a negative return on equity of 31.76%. View Greenlane's earnings history.

2 analysts have issued 1 year price objectives for Greenlane's shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate Greenlane's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 16.3% from the stock's current price. View analysts' price targets for Greenlane.

Headlines about GNLN stock have trended very negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Greenlane earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news aboutGreenlane.

Some companies that are related to Greenlane include Medifast (MED), Fresh Del Monte Produce (FDP), Universal (UVV), United Natural Foods (UNFI), Calavo Growers (CVGW), Scholastic (SCHL), John B. Sanfilippo & Son (JBSS), Schweitzer-Mauduit International (SWM), e.l.f. Beauty (ELF), Purple Innovation (PRPL), Greencore Group (GNCGY), Meredith (MDP), Matthews International (MATW), Celsius (CELH) and MGP Ingredients (MGPI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlane investors own include Ovid Therapeutics (OVID), Curaleaf (CURLF), Enphase Energy (ENPH), KushCo (KSHB), Aurora Cannabis (ACB), Inovio Pharmaceuticals (INO), Roku (ROKU), Walt Disney (DIS), Trulieve Cannabis (TCNNF) and Energy Transfer LP Unit (ET).

(GNLN) raised $80 million in an IPO on Thursday, April 18th 2019. The company issued 5,300,000 shares at a price of $14.00-$16.00 per share. Cowen and Company and Canaccord Genuity served as the underwriters for the IPO and Ladenburg Thalmann, Roth Capital Partners and Northland Securities were co-managers.

Greenlane trades on the NASDAQ under the ticker symbol "GNLN."

Greenlane's stock is owned by a number of institutional and retail investors. Top institutional shareholders include UBS Group AG (0.72%), BlackRock Inc. (0.58%), FNY Investment Advisers LLC (0.55%), Healthcare Value Capital LLC (0.24%), AdvisorShares Investments LLC (0.20%) and State Street Corp (0.14%). Company insiders that own Greenlane stock include Aaron Locascio, Jacoby & Co Inc, Jay M Scheiner, Pura Vida Investments, Llc, Richard Taney and Sasha Kadey. View institutional ownership trends for Greenlane.

GNLN stock was sold by a variety of institutional investors in the last quarter, including Squarepoint Ops LLC, and UBS Group AG. View insider buying and selling activity for Greenlane.

GNLN stock was bought by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, State Street Corp, Healthcare Value Capital LLC, BlackRock Inc., Nuveen Asset Management LLC, and AdvisorShares Investments LLC. Company insiders that have bought Greenlane stock in the last two years include Aaron Locascio, Pura Vida Investments, Llc, and Richard Taney. View insider buying and selling activity for Greenlane.

Shares of GNLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GNLN stock can currently be purchased for approximately $3.44.

Greenlane has a market capitalization of $323.19 million and generates $185.01 million in revenue each year. The company earns $-28,820,000.00 in net income (profit) each year or $0.36 on an earnings per share basis. Greenlane employs 249 workers across the globe.

The official website for Greenlane is www.gnln.com.

Greenlane's mailing address is 1095 BROKEN SOUND PARKWAY SUITE 300, BOCA RATON FL, 33487. The company can be reached via phone at 877-292-7660 or via email at [email protected]